According to the CDC, Clostridium difficile is now the most common microbial healthcare associated infection with annual health care cost exceeding $4.8 billion.
Approximately 15,000 deaths are attributable to C. difficile infection each year in the U.S.A.
Why to choose it
A high-throughput, simplified workflow without DNA isolation that provides results in about an hour.
Rapid results and high-throughput
The Simplexa® C. difficile Universal Direct assay allows you to perform up to 94 patient samples per run with results in about 1 hour.
High quality data that you can trust
The Simplexa® C. difficile Universal Direct assay delivers diagnostic confidence with greater than 99% positive agreement.
|Reference PCR||N||Positive||Negative||% Agreement|
|Reference PCRPositive||N110||Positive109||Negative1||% Agreement99.1% (109/110)
95% CI: 95-99.8%
|Reference PCRNegative||N79||Positive7||Negative72||% Agreement91.1% (72/79)
95% CI: 82.8-95.6%
Simplexa® C. difficile Universal Direct
|Code MOL2975||Reactions 100|